CEO SUMMARY: Just four weeks remain before CMS begins collecting private payer clinical laboratory test price data. Many lab industry executives have charged that Medicare officials are not following the language of the PAMA statute or the intent of Congress. At stake are $5.4 billion in Part B fee cuts that CMS plans to introduce. […]
Should Labs File Court Challenge To PAMA Price Report Rule?
In 2008, several labs sued HHS and obtained an injunction that stopped competitive bidding
- By Robert Michel
- > From the Volume XXIII No. 16 - November 28, 2016 Issue
- Tags: clinical lab, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical laboratory industry, clinical laboratory test, clinical laboratory testing, clinical labs, competitive bid, genetic test, genetic testing, hospital laboratories, lab industry, lab test, lab testing, lab testing services, laboratories, laboratory fee schedule, laboratory industry, laboratory medicine, laboratory outreach, laboratory outreach program, laboratory test, laboratory testing, Medicare, Medicare Part B, molecular diagnostic, pathologists, private payer, the clinical laboratory, xifin
